Search

everythinglearnresearchcommunity

for

Search:↓

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Young women with PCOS and no other heart risk factors have normal heart function.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Chemotherapy caused a woman's permanent hair loss and early menopause.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.